{
  "_id": "5f73fe3bdcb961bf32d76417fd919f0df6aa44a1f66d61bd302c71dc878d52ba",
  "feed": "ftcomall",
  "title": "The great medicines migration: how China controls key drug supplies",
  "text": "<p>In the spring of 2020, as the Covid-19 pandemic took hold, many pharmaceutical companies faced disruptions to their supply chains. Chemicals used to produce the key ingredients in drugs were often sourced from only a few suppliers in China — sometimes from just one.</p> <p>The pandemic has brought to light just how much the global pharmaceutical supply chain depends on China, even for the most basic ingredients.</p> <p>This is the final instalment of a Nikkei Asia series on Beijing's aim to become the centre of the global drug industry. This instalment focuses on China's market command for active pharmaceutical ingredients — a dominance some western countries are challenging as Covid-19 and geopolitical tensions expose supply-chain vulnerabilities. </p> <p>Read more <a href=\"https://asia.nikkei.com/static/vdata/infographics/chinavaccine-3/\" title=\"\">here</a>.</p> <p><a href=\"https://asia.nikkei.com/Business/Pharmaceuticals/The-great-medicines-migration-How-China-controls-key-drug-supplies\"><em>A version of this article</em></a><em> was first published by Nikkei</em> <em>Asia on April 5 2022. ©2022 Nikkei Inc. All rights reserved</em></p> <h2>Related stories</h2> <ul>  <li><p><a href=\"https://asia.nikkei.com/Spotlight/Coronavirus/COVID-vaccines/China-s-global-vaccine-gambit-Production-politics-and-propaganda\">China's global vaccine gambit: Production, politics and propaganda</a></p></li>  <li><p><a href=\"https://asia.nikkei.com/Spotlight/Coronavirus/COVID-vaccines/Pharmacy-of-the-world-China-s-quest-to-be-the-No.-1-drugmaker\">Pharmacy of the world: China's quest to be the No. 1 drugmaker</a></p></li>  <li><p><a href=\"https://asia.nikkei.com/Spotlight/Coronavirus/Chinese-healthcare-companies-hit-COVID-jackpot-with-home-test-kits\">Chinese healthcare companies hit COVID jackpot with home-test kits</a></p></li>  <li><p><a href=\"https://asia.nikkei.com/Spotlight/Coronavirus/China-s-new-COVID-lockdowns-hit-Apple-suppliers\">China's new COVID lockdowns hit Apple suppliers</a></p></li> </ul><p>Source: Nikkei staff writers 2022 'The great medicines migration: how China controls key drug supplies' FT.com 12 April. Used under licence from the Financial Times. © The Financial Times Limited 2022. All Rights Reserved. </p><p>Please do not cut and paste FT articles and redistribute by email or post to the web.</p>",
  "published": "2022-04-12T02:00:53.439Z",
  "tags": [
    {
      "id": "US0378331005",
      "nexusId": "10022657",
      "name": "Apple Inc.",
      "offsets": [
        {
          "start": 1122,
          "end": 1127
        }
      ]
    }
  ]
}